Abeona Therapeutics (ABEO)
NASDAQ:ABEO
Abeona Therapeutics (ABEO) Ownership Overview
7.20% Insiders
7.09% Mutual Funds
45.04% Other Institutional Investors
9.20% ETFs
31.46% Public Companies and
Individual Investors
The ownership structure of Abeona Therapeutics (ABEO) stock is a mix of institutional, retail, and individual investors. Approximately 61.33% of the company’s stock is owned by Institutional Investors, 7.20% is owned by Insiders, and 31.46% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 16, 2026 | xxxxxxxxxxxxx | $3737 | |
Feb 04, 2026 | xxxxxxxxxxxxx | $102156 | |
Feb 02, 2026 | xxxxxxxxxxxxx | $82886 | |
Feb 02, 2026 | xxxxxxxxxxxxx | $75403 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $210800 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,340,715 | Institution | 4.32% | 11,141,803 | |
| 2,089,615 | Institution | 3.86% | 9,946,567 | |
| 1,652,368 | Institution | 3.05% | 7,865,272 | |
| 1,460,408 | Insider | 2.69% | 6,951,542 | |
| 1,249,957 | Institution | 2.31% | 5,949,795 | |
| 568,560 | Insider | 1.05% | 2,706,346 | |
| 507,988 | Institution | 0.94% | 2,418,023 | |
| 502,711 | Institution | 0.93% | 2,392,904 | |
| 479,270 | Institution | 0.88% | 2,281,325 | |
| 451,134 | Insider | 0.83% | 2,147,398 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,089,615 | Institution | 3.86% | 9,946,567 | |
| 502,711 | Institution | 0.93% | 2,392,904 | |
| 479,270 | Institution | 0.88% | 2,281,325 | |
| 255,003 | Institution | 0.47% | 1,213,814 | |
| 132,884 | Institution | 0.25% | 632,528 | |
| 120,176 | Institution | 0.22% | 572,038 | |
| 56,719 | Institution | 0.10% | 269,982 | |
| 41,020 | Institution | 0.08% | 195,255 | |
| 27,928 | Institution | 0.05% | 132,937 | |
| 26,710 | Institution | 0.05% | 127,140 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,529,026 | Institution | 2.82% | 7,782,742 | |
| 1,048,454 | Institution | 1.93% | 4,990,641 | |
| 560,589 | Institution | 1.03% | 2,853,398 | |
| 500,342 | Institution | 0.92% | 2,479,195 | |
| 348,219 | Institution | 0.64% | 1,657,522 | |
| 208,227 | Institution | 0.38% | 1,059,875 | |
| 185,877 | Institution | 0.34% | 921,021 | |
| 115,861 | Institution | 0.21% | 551,498 | |
| 115,172 | Institution | 0.21% | 548,219 | |
| 97,676 | Institution | 0.18% | 464,938 |
FAQ
Who Owns Abeona Therapeutics (ABEO)?
According to the latest TipRanks data, approximately 45.04% of the company's stock is held by institutional investors, 7.20% is held by insiders, and 31.46% is held by retail investors.
What percentage of Abeona Therapeutics (ABEO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 45.04% of Abeona Therapeutics (ABEO) stock is held by institutional investors.
What percentage of Abeona Therapeutics (ABEO) stock is held by retail investors?
According to the latest TipRanks data, approximately 31.46% of Abeona Therapeutics (ABEO) stock is held by retail investors.
Who owns the most shares of Abeona Therapeutics (ABEO)?
Vanguard owns the most shares of Abeona Therapeutics (ABEO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.